-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AfGpevzTeDDsf7kYD+/9+Tff5eOTauTwUZu5VmHu6YoWs5UqAFd2elIYIr0x7p7y 8S/VVs7prybukFo6iAenlA== 0000950136-02-000215.txt : 20020414 0000950136-02-000215.hdr.sgml : 20020414 ACCESSION NUMBER: 0000950136-02-000215 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020125 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: APAX PARTNERS INC CENTRAL INDEX KEY: 0000938219 IRS NUMBER: 132647531 STATE OF INCORPORATION: NY FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 445 PARK AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127536300 MAIL ADDRESS: STREET 1: 445 PARK AVENUE STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: PATRICOF & CO VENTURES INC DATE OF NAME CHANGE: 19950315 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: RITA MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0001056421 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943199149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-60199 FILM NUMBER: 02517777 BUSINESS ADDRESS: STREET 1: 967 N SHORELINE BLVD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94013 BUSINESS PHONE: 6503858500 MAIL ADDRESS: STREET 1: 967 NORTH SHORELINE BLVD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 SC 13G/A 1 file001.txt AMENDMENT TO SCHEDULE 13G ----------------------------- OMB APPROVAL ----------------------------- OMB Number: 3235-0145 ----------------------------- Expires: October 31, 2002 ----------------------------- Estimated average burden hours per response. . . 14.9 ----------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* Rita Medical Systems - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 76774E103 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 2001 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) - ------------- * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
- -------------------------------------------- ---------------------------- ------------------------------------------ CUSIP NO. 76774E103 PAGE 2 OF 6 PAGES - --------- ---------------------------------------------------------------------------------------------------------- 1. NAMES OF REPORTING PERSONS IRS IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Apax Partners, Inc. 13-2647531 - --------- ------------------------------------------------------------------------------------------- -------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] - --------- ---------------------------------------------------------------------------------------------------------- 3. SEC USE ONLY - --------- ---------------------------------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION New York - ----------------------- ---------- --------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER SHARES 0 BENEFICIALLY ---------- --------------------------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER EACH 1,963,635 REPORTING ---------- --------------------------------------------------------------------------------- PERSON WITH 7. SOLE DISPOSITIVE POWER 0 ---------- --------------------------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER 1,963,635 - --------- ---------------------------------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,963,635 - --------- ------------------------------------------------------------------------------------------- -------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - --------- ---------------------------------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 13.51% - --------- ---------------------------------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON (See Instructions) CO - --------- ----------------------------------------------------------------------------------------------------------
Page 3 of 6 Pages Item 1. (a) Name of Issuer: Rita Medical Systems (b) Address of Issuer's Principal Executive Offices: 967 North Shoreline Boulevard, Mountainview, CA 94043 Item 2. (a) Name of Person Filing: Apax Partners, Inc. (b) Address of Principal Business Office or, if none, Residence: 445 Park Avenue, New York, NY 10022 (c) Citizenship: New York (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 75774E103 Item 3. If this statement is filed pursuant to Rule 13d-1(b) or Rule 3d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act. (b) [ ] Bank as defined in Section 3(a)(6) of the Act. (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act. (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940. (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E). (f) [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F). (g) [ ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G). (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act. (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940. (j) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). Page 4 of 6 Pages Item 4. Ownership. (a) Amount beneficially owned: _________1,963,635____. (b) Percent of class: ___________________13.51%______. (c) Number of shares such person has: (i) Sole power to vote or to direct the vote ____0______. (ii) Shared power to vote or to direct the vote __1,963,635_____________. (iii) Sole power to dispose or to direct the disposition of __ 0______________. (iv) Shared power to dispose or to direct the disposition of _1,963,635 _____. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Page 5 of 6 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 24, 2002 ----------------------------------- (Date) /s/ George M. Jenkins ----------------------------------- (Signature) George M. Jenkins, Vice President ----------------------------------- (Name/Title) The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties for whom copies are to be sent. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001) Page 6 of 6 Pages Rider A As of December 31, 2001, Apax Partners, Inc. ("Apax") may be deemed to be the beneficial owner of 1,607,489 shares of common stock (11.08%) owned by APA Excelsior V, L.P., a Delaware Limited Partnerships, 336,623 shares of common stock (2.3%) owned by the P/A Fund III, L.P., a Pennsylvania Limited Partnership and 19,523 shares of common stock (0.13%) owned by Patricof Private Investment Club II, L.P., a Delaware Limited Partnership. Each of such entities is managed or advised by Apax and, as such, Apax may be deemed to have shared voting and dispositive power with the General Partners of each Partnership with respect to an aggregate of 1,963,635 shares of common stock. -----END PRIVACY-ENHANCED MESSAGE-----